PNC Financial Services Group’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
PCM
PNC Financial Services Group's PLSE Position: Q2 2026 in Review
PNC Financial Services Group reduced its Pulse Biosciences (PLSE) stake by 75% in Q2 2026, selling an estimated $98.8K and leaving 1,398 shares worth $38.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3482.
PNC Financial Services Group first reported a position in PLSE in Q1 2017 and has held it in 28 quarters since. The position peaked at $242K in Q4 2023. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- PNC Financial Services Group held 1,398 shares of Pulse Biosciences worth $38.8K as of Q2 2026.
- PNC Financial Services Group sold 4,187 Pulse Biosciences shares in Q2 2026, an estimated $98.8K.
- Pulse Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3482 holding.
- PNC Financial Services Group first reported a position in Pulse Biosciences in Q1 2017 and has held it in 28 quarters since.
- PNC Financial Services Group's Pulse Biosciences position peaked at $242K in Q4 2023.
- 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.